Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: A nationally representative cross-sectional survey

• Published in: Vaccine Vol. 41; no. 48; pp. 7147 - 7158
• Main Authors: Terada, Marina, Shimazu, Taichi, Saito, Junko, Odawara, Miyuki, Otsuki, Aki, Yaguchi-Saito, Akiko, Miyawaki, Rina, Kuchiba, Aya, Ishikawa, Hirono, Fujimori, Maiko, Kreps, Gary L.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 22.11.2023; Elsevier Limited
• Subjects: Adult; Age; Awareness; Cross-Sectional Studies; Disparity; East Asian People; Education; Effectiveness; Female; Females; Gender; Gender: socioeconomic status; Health Knowledge, Attitudes, Practice; Health literacy; HPV vaccine; Human papillomavirus; Human Papillomavirus Viruses; Human papillomaviruses; Humans; Immunization; Knowledge; Low level; Male; Males; Middle Aged; Papillomavirus Infections - prevention & control; Papillomavirus Vaccines; Socioeconomic Disparities in Health; Socioeconomic factors; Socioeconomics; Subpopulations; Surveys; Surveys and Questionnaires; Vaccination; Vaccine efficacy; Vaccines; Young Adult; United States > US; Japan; Human papillomaviruses; Health literacy; Awareness; Gender: socioeconomic status; Disparity; Cross-sectional studies; HPV vaccine; Knowledge
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2023.10.024

The Japanese government’s 2013 suspension of its proactive recommendation for Human papillomavirus (HPV) vaccination resulted in low HPV vaccination coverage and was unique. However, data on awareness and knowledge of HPV vaccines in the general population was limited. Here, to investigate more recent awareness and knowledge of HPV vaccines by age, gender, and socioeconomic status, we used data from the INFORM Study 2020, a nationally representative cross-sectional survey of self-administered questionnaires with 1,998 Japanese individuals aged 20 to 59 years. We found that 47.5% of females and 21.0% of males had heard of HPV, and 33.6% of females and 16.8% of males had knowledge of HPV vaccine efficacy. After adjusting for potential confounders, females aged 50–54 years were more likely to be aware of HPV than females aged 20–24 (AOR, 2.02, 95%CI: 1.12–3.65). Females (AOR, 2.13, 95%CI: 1.48–3.07) and males (AOR, 1.64, 95%CI: 1.03–2.59) with higher education had more awareness than those with less education. Females with higher education had more knowledge about HPV vaccine efficacy than those with less education (AOR, 1.70; 95%CI: 1.16–2.50). We found a generally low level of awareness and knowledge about HPV vaccines in Japan, which might be attributable to the suspension of proactive recommendations. Additionally, we identified disparities in awareness and knowledge by age, gender, socioeconomic status, and health literacy. Enhancing HPV awareness and understanding of HPV vaccines and implementing targeted efforts for specific subpopulations within Japan after the resumption of proactive recommendation for HPV vaccines, are imperative.